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A B S T R A C T
Focal cortical dysplasias (FCDs) are a range of malformations of cortical development each with speciﬁc
histopathological features. Conventional radiological assessment of standard structural MRI is useful for the
localization of lesions but is unable to accurately predict the histopathological features. Quantitative MRI oﬀers
the possibility to probe tissue biophysical properties in vivo and may bridge the gap between radiological
assessment and ex-vivo histology. This review will cover histological, genetic and radiological features of FCD
following the ILAE classiﬁcation and will explain how quantitative voxel- and surface-based techniques can
characterise these features. We will provide an overview of the quantitative MRI measures available, their link
with biophysical properties and ﬁnally the potential application of quantitative MRI to the problem of FCD
subtyping. Future research linking quantitative MRI to FCD histological properties should improve clinical
protocols, allow better characterisation of lesions in vivo and tailored surgical planning to the individual.
1. Introduction
Cortical dysplasias are malformations of brain development that are
highly epileptogenic. They are a common cause of drug-resistant focal
epilepsy in adults and the most common cause in children, the under-
lying aetiology in 42% of paediatric epilepsy surgery cases (Harvey
et al., 2008). Resective surgery is the most eﬀective treatment to
eliminate seizures in drug-resistant focal epilepsy population (Fauser
et al., 2004), provided there is a well-characterised epileptic focus.
Focal cortical dysplasia (FCD) encompasses a broad spectrum of
histopathological and genetic abnormalities. There have been a number
of diﬀerent classiﬁcation systems but in 2011 the International League
Against Epilepsy (ILAE) developed a three-tiered classiﬁcation system.
According to the ILAE, FCD type I has abnormal radial and/or
tangential lamination, FCD type II is also associated with aberrant
cytology, speciﬁcally dysmorphic neurons, and FCD type III occurs
alongside another lesion, e.g. hippocampal sclerosis or tumours
(Blumcke et al., 2011). From the genetic perspective FCD subtypes
are characterised by a complex interplay between many signalling
molecules involved mostly, but not exclusively, in the mTOR pathway.
Non-invasive subtype classiﬁcation is crucial for several clinical
reasons. First, the epileptogenicity of FCD is related to the histopatho-
logical features (Boonyapisit et al., 2003). Second, surgical planning is
signiﬁcantly improved when lesions are identiﬁed on pre-operative MRI
(Téllez-Zenteno et al., 2010) and variability in outcome is seen
according to FCD subtypes, with type I and type IIA having poorer
post-surgical outcomes than type IIB (Hong et al., 2015; Mühlebner
et al., 2011). This may be explained by the fact that those subtypes
often present more diﬀuse or subtle lesions, with poorly deﬁned
boundaries (Blumcke et al., 2011; Hong et al., 2015). The ability to
characterise FCD subtypes in vivo is therefore clinically relevant as it is
informative of post-surgical seizure freedom as well as providing a
mechanism for exploring aetiological risk factors and research into
cognitive trajectories within speciﬁc aetiological subtypes.
Radiological assessments carried out on conventional structural MRI
indicate that subtypes may have diﬀerentiating MRI features, i.e. they
can be distinguished by combinations of morphological and image
intensity features (Blumcke et al., 2011). However, visual deﬁnition of
histological characteristics on pre-surgical MRI is challenging and often
inconclusive (Kim et al., 2012).
Two converging areas of imaging research oﬀer the possibility for
more speciﬁc quantitative measurements of brain structure. The ﬁrst is
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computational anatomy, which we deﬁne as the automated extraction
of morphological features and statistical analysis of grey and white
matter maps from MRI images such as T1- and T2-weighted (respec-
tively T1w and T2w), or Fluid Attenuated Inversion Recovery (FLAIR);
a T2w image with nulled CSF signal. These morphological features can
then be correlated with histopathological and genetic characteristics.
The second area is quantitative MRI, which provides an estimate of
the parameters governing the conventional image intensity. Standard
structural MRI data, such as T1w and T2w, are able to delineate the
brain anatomy but are not speciﬁc to tissue property variations. A
change in image intensity can be caused by a range of underlying
neurobiological processes. Quantitative MRI (qMRI) parameters are
speciﬁc to tissue structure and biophysical properties at the micrometre
scale. These parameters are neuroimaging biomarkers for myelin, water
and iron content (Bilgic et al., 2012; Deoni et al., 2015; Schweser et al.,
2011), and provide the MRI “ﬁngerprints” (Ma et al., 2013) of brain
tissue microstructure (Weiskopf et al., 2013). By linking brain tissue
property changes with image intensity, qMRI may assist understanding
of the neurobiological mechanisms underlying a change in morphome-
try.
Until recently, qMRI has not been available in a clinical setting due
to scan duration and greater complexity in image reconstruction.
However, advances in image acquisition now oﬀer the possibility to
probe the in vivo tissue microstructure in a clinical setting (Deoni et al.,
2015; Weiskopf et al., 2013) with high signal to noise ratio. Further-
more, the increased availability of high ﬁeld strength (7 Tesla) MRI will
enable MRI to be performed at higher resolution and using new contrast
mechanisms (Kozlov and Turner, 2010).
Temporal lobe epilepsy is one of the few conditions where qMRI has
been routinely used in a clinical setting to diﬀerentiate healthy from
sclerotic hippocampi as well as to infer histological and connectivity
changes in brain areas. T2 mapping has been shown to signiﬁcantly
outperform FLAIR in diﬀerentiating sclerotic from healthy hippocampi
(Rodionov et al., 2015). Furthermore, histological analysis of resected
brain regions has shown that multiple linear regression models using T1
and T2 mapping can accurately predict neuronal loss in hippocampal
subﬁelds (Goubran et al., 2015).
The ﬁrst goal of this review is to report current understanding of
histological, genetic and radiological features of FCD lesions. We then
investigate the link between those characteristics and the computa-
tional anatomy measures reported in the literature. We consider the
beneﬁt of using qMRI estimates in the context of FCD subtyping (Fig. 1).
Finally, we discuss the need for combinations of computational
anatomical features with “in vivo histology” provided by qMRI for
non-invasive lesion characterisation.
2. Histopathology of focal cortical dysplasia
The ﬁrst detailed descriptions of FCDs were provided by Taylor and
colleagues in 1971 (Taylor et al., 1971). The newest classiﬁcation
scheme, provided by the ILAE, has improved inter-observer agreement
among expert neuropathologists (Coras et al., 2012). In this review we
focus mainly on FCD types I, IIA and IIB (see Table 1).
2.1. FCD type I
FCD type I is characterised by isolated lesions in the neocortex with
radial (type IA) or tangential (type IB) cortical dyslamination, or a
mixture of both (type IC).
In FCD type IA the radial cortical dyslamination manifests with
prominent microcolumns (Blumcke et al., 2011). A “microcolumn” is
deﬁned as at least 8 neurons aligned in a vertical orientation within the
cortex (Rakic, 1988). During cortical development, radial units form
that consist of cells that originate from progenitor stem cells, share the
same birthplace, migrate along the same pathway and reside in the
cortex within the same ontogenetic column. The micro-columnar
disorganization in FCD type IA is most prominent within layer 3. These
lesions are characterised by a thinner neocortex and higher neuronal
densities (Mühlebner et al., 2011). Furthermore, the grey-white matter
boundary is usually less easily deﬁned due to increased numbers of
heterotopic neurons.
In FCD type IB the normal 6-layered composition of the cortex is
disrupted. There may be no identiﬁable layers in the neocortex, or
disruptions may be restricted to abnormal layering of layer 2, layer 4, or
both (Blumcke et al., 2011).
2.2. FCD type II
In focal cortical dysplasia type II, in addition to disrupted cortical
lamination, there are speciﬁc cytologic abnormalities. Both FCD types
IIA and IIB have dysmorphic neurons characterised by increased size,
abnormal orientation and abnormal cytoarchitecture with an indistinct
border between the grey matter and white matter.
FCD Type IIB is deﬁned by the presence of balloon cells (Blumcke
et al., 2011). These cells have large bodies, eosinophilic cytoplasm,
which lacks Nissl substance, and have eccentric, sometimes multiple
nuclei (Blumcke et al., 2011). They can be located in any layer of the
cortex or in the underlying white matter but are frequently found in the
subcortical white matter or in superﬁcial cortical layers. The nature of
balloon cells is uncertain but a few studies suggest that they are related
to progenitor cells (reviewed by Yasin et al., 2010). Furthermore, they
show a defect in the cellular process of autophagy, which is dependent
on overactivity of the serine/threonine kinase, mTOR (Yasin et al.,
2013). FCD type IIB lesions also exhibit changes in myelination that are
hypothesised to result from aberrant oligodendroglial cell diﬀerentia-
tion and reduced neuronal cell densities (Mühlebner et al., 2011).
Distinguishing FCD subtypes and diﬀerentiating them from other
neurodevelopmental abnormalities, on histopathological review can be
challenging. Although FCD types IIA and IIB can be consistently
diﬀerentiated, FCD type I subtypes are more diﬃcult to distinguish
and the accurate histopathological classiﬁcation of these less subtypes
is related to the level of expertise and training of the neuropathologist
(Coras et al., 2012). Furthermore, heterogeneity in the histopathologi-
cal appearance of a lesion is often found within an individual further
complicating classiﬁcation.
3. Genetics of the focal cortical dysplasias
In recent years, much evidence has accumulated for the common
genetic origin of focal epilepsy with FCD (Baulac et al., 2015), with
causative pathogenic variants present in the germ line of rare familial
cases (see Table 1). An interesting example is the DEPDC5 gene
involved both in pathogenesis of a typical genetic epilepsy syndrome
(familial focal epilepsy with variable foci – FFEVF) and of FCD (Baulac
et al., 2015). DEPDC5 codes for a subunit of GATOR1 complex, an
upstream regulator of the mTORC1 protein. In addition, pathogenic
variants in the DEPDC5 gene have been identiﬁed in a case of
hemimegalencephaly with the histological pattern of FCD IIA (Mirzaa
et al., 2016). Furthermore, a study of familial cases of histologically
conﬁrmed FCD IIA identiﬁed germ line pathogenic variants in NPRL3
gene, another mTOR regulator (Sim et al., 2016).
The mTOR pathway has generated great interest in the ﬁeld of
genetic research of various malformations of cortical development, FCD
being among them. Indeed, the histological pattern of FCD IIB lesions is
identical or closely resembles that of cortical tubers in tuberous
sclerosis complex (TSC) and hemimegalencephaly (Majores et al.,
2005). Therefore, it has been hypothesised that, given their similarities,
these lesions might share a common genetic background. Since
pathogenic variants in TSC1 and TSC2 genes have long been known
to cause TSC, they have also been studied in FCD lesions, and
pathogenic variants of TSC1 gene discovered in FCD IIB brain tissue
samples (Becker et al., 2002). Furthermore, interesting allelic variants
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Fig. 1. Overview of relationship between histological features, biophysical tissue properties, MR images, computational anatomy measures and quantitative neuroimaging. Green arrow
indicates current link between MR-weighted images and ex vivo histology. Orange arrows indicate areas of current research using computational anatomy based on MR-weighted images
for FCD subtyping. Blue arrows indicate future directions to characterise biophysical tissue properties of FCDs using qMRI. qMRI maps are sensitive to biophysical tissue properties, such
as myelin, iron, calcium and free water content. The qMRI proﬁles of diﬀerent FCD subtypes are currently unknown but may oﬀer a technique to probe histology in vivo. (For
interpretation of the references to color in this ﬁgure legend, the reader is referred to the online version of this chapter.)
Table 1
Characteristics of FCD lesion subtypes. The table summarises the histological, genetic and radiological features reported to characterise lesion types.
Lesion subtype Histology Genetics Radiological features
FCD I (A & B) FCD IA: radial cortical
dyslamination
(Blumcke et al., 2011)
FCD IB: tangential cortical
dyslamination
(Blumcke et al., 2011)
• Variants in DEPDC5 (Baulac et al., 2015)• FCD IB: chromosomal rearrangement in AKT3
(Conti et al., 2015)
• Cortical thinning• Grey/white matter blurring• Signal abnormalities on T1w/T2w imaging• Lobar hypoplasia (Blumcke et al., 2011; Kabat and Król, 2012;
Kim et al., 2012; Krsek et al., 2008)
FCD IIA Dysmorphic neurons
(Blumcke et al., 2011)
• Variants in NPRL3 (Sim et al., 2016)• Variants in DEPDC5 (Mirzaa et al., 2016)• Variants of TSC2 (Majores et al., 2005)• Mutations of mTOR (Lim et al., 2015; Mirzaa
et al., 2016)
• Mutation in PI3KCA (Jansen et al., 2015)
• Cortical thickening• Grey/white matter blurring• Signal abnormalities on T1w/T2w imaging• Abnormal gyriﬁcation (Kabat and Król, 2012; Krsek et al., 2008)
FCD IIB Dysmorphic neurons and balloon
cells
(Blumcke et al., 2011)
• Variants of TSC1 (Becker et al., 2002)• Mutations of mTOR (Lim et al., 2015; Mirzaa
et al., 2016)
• Variant in exon 8 of PTEN (Weiskopf et al.,
2013)
• Cortical thickening• Grey/white matter blurring• Signal abnormalities on T1w/T2w imaging• Transmantle sign• Abnormal gyriﬁcation (Kim et al., 2012; Mühlebner et al., 2011)
(Barkovich et al., 1997)
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of TSC2 gene have been observed in FCD IIA samples (Majores et al.,
2005), contributing to the evidence for involvement of TSC1 and TSC2
genes, both upstream inhibitors of mTOR signalling. In contrast to these
ﬁndings, no clear causative pathogenic variants were found for either
TSC1 or TSC2 genes in brain tissue samples from a diﬀerent cohort of
FCD patients (Gumbinger et al., 2009). Somatic mutations of mTOR
gene itself were discovered in FCD IIA (Lim et al., 2015; Mirzaa et al.,
2016) and FCD IIB (Lim et al., 2015) samples.
Located further upstream of the complex PI3K-AKT-MTOR pathway,
the AKT3 and PI3KCA genes contribute to mTOR signalling, and these
are primarily involved in severe cortical malformations associated with
complex megalencephaly and hemimegalencephaly syndromes (Rivière
et al., 2012). As previously mentioned, these malformations may share
similar histological features with FCD, and we might expect similar
genetic background underlying their formation; indeed, a somatic
mutation in PI3KCA was detected in an FCD IIA brain tissue sample
(Jansen et al., 2015). In addition, somatic missense variant in exon 8 of
PTEN1 was described in an FCD IIB sample (Schick et al., 2006).
Furthermore, a chromosomal rearrangement in the region encompass-
ing the AKT3 gene was identiﬁed in the brain tissue sample of a
dysplastic frontal lobe, showing the histological pattern of FCD IB
(Conti et al., 2015).
The aforementioned examples point to the complex interplay
between many signalling molecules involved mostly, but not exclu-
sively, in the mTOR pathway. Further study of these molecules and
their interactions is warranted if we aim to understand the complex
genetic background of formation of FCD.
The intriguing possibility is that the interplay between genetic
background and the formation of the cortex may provide deﬁning
features of FCD subtypes that can be measured in vivo using qMRI.
Previous studies show that genetics aﬀects brain structure both at the
cortical and subcortical level (Hibar et al., 2015; Peper et al., 2007). So
far, the majority of studies evaluating the correlation of neuroimaging
features and genetics in epilepsy have been carried out on mesial
temporal lobe epilepsy (MTLE) patients and their asymptomatic ﬁrst-
degree relatives. Increased T2 relaxometry (Suemitsu et al., 2014),
morphological alterations (Alhusaini et al., 2016) and microstructural
white matter alterations (Whelan et al., 2015) have been discovered in
MTLE patients and their asymptomatic siblings, indicative of the
heritability of anatomical traits. However, the interrelation between
the genetics of FCDs and the neuroimaging phenotype remains to be
determined.
4. Radiological identiﬁers of focal cortical dysplasias
On T1w, T2w and FLAIR MRI scans, FCDs of all types often
demonstrate abnormal cortical thickness, an indistinct grey-white
matter junction, signal abnormalities in the subcortical white matter
and grey matter and irregular cortical folding patterns (Bernasconi
et al., 2011; Kabat and Król, 2012; Leach et al., 2014a, 2014b; Mellerio
et al., 2012). Lesion visibility can change with respect to developing
myelination in the brain, the so-called ‘disappearing’ lesion, which may
be more obvious on a scan of an unmyelinated brain in infancy but
become less distinct later in childhood (Eltze et al., 2005).
4.1. FCD type I
MR features that can assist delineation of these often subtle and
diﬃcult to discern lesions include cortical thinning, blurring of the
grey-white matter boundary and lobar or sublobar hypoplasia which
may be accompanied by atrophy of the white matter (Blumcke et al.,
2011; Kabat and Król, 2012; Kim et al., 2012; Krsek et al., 2008; Téllez-
Zenteno et al., 2010). The cortical thinning may be linked to altered
neuronal density in FCD type I (Blumcke et al., 2011). The white matter
changes may be visualised by hypointensities on T1w and hyperinten-
sities on T2w imaging. There are no visually identiﬁable diﬀerences
between the MR features of types IA and IB. However, the distribution
of these two subtypes across the cortex may be diﬀerent, with type IA
more frequently located in the temporal lobe and IB more frequently
located in extra-temporal cortex (Kabat and Król, 2012).
4.2. FCD type II
Radiological MRI features include grey-white matter blurring,
cortical thickening, white matter hypointensities on T1w and increased
signal intensity on T2w, FLAIR images as well as abnormal gyriﬁcation
patterns, often visible as an asymmetric folding pattern (Blumcke et al.,
2011).
Radiological features of FCD type IIB are the same as IIA (Kabat and
Król, 2012; Krsek et al., 2008). However, FCD type IIB can also
demonstrate the distinguishing transmantle sign, a T2w hyperintense
signal extending from the subcortical white matter to the lateral
ventricle, best seen on FLAIR and proton density images (Barkovich
et al., 1997). This white matter signal alteration might reﬂect the
involvement of glial-neuronal bands (Colombo et al., 2009), and is the
only MRI feature able to accurately identify FCD type IIB (Kim et al.,
2012; Mühlebner et al., 2011).
Increased T2w signal intensity present in the white matter of FCD
IIB has been related to the demyelination found histologically, which is
associated with severe ﬁbre loss and altered myelin sheaths, abnormal
cells and sometimes oedema (Garbelli et al., 2011; Mühlebner et al.,
2011; Zucca et al., 2016).
In light of the above, many radiological features are shared by
diﬀerent FCD subtypes (as shown in Table 1), therefore we are currently
not able to reliably distinguish subtypes on the basis of conventional
visual analysis. The remainder of this review will focus on quantitative
MRI features, and their incorporation into automated classiﬁcation
algorithms.
5. Computational anatomy
Computerised algorithms can automatically estimate diﬀerent brain
features, such as volume, thickness and shape, relying on the image
intensity and tissue contrast to determine anatomical boundaries. Both
voxel- and surface-based techniques can be used to extract morpho-
metry and intensity measures from T1w, T2w and FLAIR images to
quantify FCD lesion attributes (Guerrini et al., 2015). Voxel-based
measures include grey matter and white matter density, also referred to
as volume (House et al., 2013; Huppertz et al., 2005), while surface-
based features include cortical thickness, sulcal depth, curvature, local
gyriﬁcation index and intensity sampling (Adler et al., 2016; Ahmed
et al., 2015; Hong et al., 2015). These techniques quantify whole-brain
structural abnormalities and group-level patterns have been used to
dissociate FCD subtypes. For example, surface-based techniques have
been used to quantify cortical thinning in FCD type I, and cortical
thickening and decreased folding complexity in FCD type II (Hong
et al., 2016).
However, overall there is a dearth of computational anatomy
ﬁndings diﬀerentiating lesion subtypes. This may be explained by the
fact that current measures derived from T1w and T2w data are aﬀected
by a mix of tissue properties that may have confounding eﬀects on
tissue contrast and hence reduce the sensitivity of computational
anatomy measures. For example, comparisons between histology- and
MRI-based measures of cortical thickness generally show good corre-
spondence (Fischl and Dale, 2000; Scholtens et al., 2015; Song et al.,
2015). However, MRI-based morphological measures can be con-
founded by other microstructural changes, such as pronounced cortical
myelination in the motor cortex blurring the grey-white boundary and
leading to underestimates of cortical thickness (Glasser and Van Essen,
2011; Scholtens et al., 2015). This is particularly problematic in FCDs
where blurring is a characteristic abnormality (Blumcke et al., 2011).
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6. Quantitative MRI (qMRI)
As indicated above, anatomical variations detected from structural
MRI data (e.g. T1w, T2w, FLAIR) might be due to true morphological
alterations or can be the results of changes in MRI contrast due to
biophysical tissue properties, such as water, myelin and iron content, at
the microstructural scale (Lorio et al., 2016; Weiskopf et al., 2013).
Quantitative MRI provides measures of parameters that can be used as
biomarkers of speciﬁc tissue properties (Table 2; Tofts, 2005). Here we
brieﬂy describe the current range of MRI parameters that can be
measured in a clinically relevant timescale (see Table 2). This is limited
to MRI features available at mm resolution and therefore excludes MR
spectroscopy, which can measure brain metabolites directly typically at
a cm scale in the human brain.
6.1. T1 relaxation time
T1 relaxation time is mainly aﬀected by myelin and water content
(Table 2; Rooney et al., 2007; Stüber et al., 2014; Waehnert et al.,
2016). For this reason many studies have used T1 relaxometry to map
the in vivo myeloarchitecture of the cerebral cortex at 3T and 7T,
highlighting densely myelinated primary and extra-striate visual areas
(Lutti et al., 2014). Previous studies showed high similarity between T1
value changes across cortical layers and myelin histological staining in
those brain regions (Lutti et al., 2014; Waehnert et al., 2016). This
underlies the sensitivity of qMRI to subtle variations in tissue proper-
ties, particularly at high ﬁeld strength, and highlights the possibility to
perform the parcellation of the cerebral cortex from in vivo MRI data
(Lutti et al., 2014; Waehnert et al., 2016). This is particularly relevant
for FCD where normal cortical layering is perturbed. In addition, FCD
provides an opportunity to evaluate the correspondence between MRI
derived cortical structure measurements with histological data in
surgical patients.
6.2. Magnetization transfer (MT)
Another MRI parameter relevant for FCD lesion characterisation is
magnetization transfer (MT) imaging. MT speciﬁcally targets the
exchange of magnetization between protons bound to macromolecules
and water protons and is thought to be the MRI biomarker most speciﬁc
to myelin content (Table 2; Graham and Henkelman, 1999).
6.3. Proton density (PD)
Altered amount of tissue water can be measured using proton
density (PD), a parameter sensitive to the density of MRI-visible
protons, which are mainly present in tissue water (Table 2; Tofts,
2005). The non-aqueous protons, such as the ones bound to macro-
molecules, are MRI invisible and do not contribute to the PD signal
(Neeb et al., 2008).
6.4. Transverse relaxation time (T2)
T2 (=1 / R2) is the transverse relaxation time, which is related to is
related to water mobility, iron deposition, myelin and glial cell count
(Table 2; Briellmann et al., 2002). The eﬀective transverse relaxation
parameter that describes the signal decay including main magnetic ﬁeld
inhomogeneities is known as T2*. T2 and T2* are related by the
following equation:
1
T2
= 1
T2′
+ 1
T2∗
where T2′ is the additional relaxation related to the presence of
inhomogeneities.
T2* is sensitive to local magnetic ﬁeld perturbations caused by the
presence of paramagnetic substances such as iron. Previous studies
demonstrated high correlation of the eﬀective transverse relaxation rate
R2* (=1 / T2*) with iron concentration measured in ferritin-rich
structures (Table 2; Langkammer et al., 2010; Yao et al., 2009).
However R2* is also sensitive to global sources of ﬁeld perturbations,
such as those from air-water interfaces. Those perturbations cause
strong signal changes unrelated to microstructure in basal temporal and
frontal brain regions.
6.5. Phase-based susceptibility MRI
Phase-based susceptibility MRI provides images sensitive to the
local microscopic magnetic agents while removing global sources of
magnetic ﬁeld perturbations increasing their potential speciﬁcity to
microstructural tissue properties (Table 2). These techniques can
distinguish between paramagnetic haemorrhage and diamagnetic cal-
ciﬁcation (Gupta et al., 2001). Molecular magnetic dipoles (e.g. ferritin
core) aligning to the static magnetic ﬁeld, increase the local suscept-
ibility depending on dipole strength and concentration, while highly
myelinated ﬁbres exhibits the lowest susceptibilities in brain
(Langkammer et al., 2010; Liu et al., 2011; Yao et al., 2009).
6.6. Diﬀusion MRI
The MRI signal can be sensitised to the microscopic movement of
water self-diﬀusion, that is the random translational motion of water
molecules (Johansen-Berg and Behrens, 2013). In tissue, diﬀusion is
hindered by the semipermeable cell membranes, which couple the
diﬀusivity in extra- and intracellular sub-spaces. Over the last 20 years
diﬀusion has been based on a tensor model of unhindered diﬀusion
allowing for the estimation of diﬀusion parameters such as fractional
anisotropy (FA) and mean diﬀusivity (MD). FA characterises the
directional preference (most preferred/least preferred) of water diﬀu-
sion in tissue. The presence of highly organised ﬁbres and cell
proliferation increase FA, as the water molecules move along the ﬁbre
direction (Table 2; Beppu et al., 2003; Johansen-Berg and Behrens,
2013). Whereas axonal directional dispersion, cellular inﬂammation
and demyelination decrease FA, as water molecules tend to move in all
directions (Table 2; Basser and Pierpaoli, 2011; Johansen-Berg and
Behrens, 2013; Werring et al., 1999).
MD reﬂects the average magnitude of molecular displacement by
diﬀusion. It can be seen as an inverse measure of the membrane density.
Brain oedema and demyelination increase MD values, whereas cell
proliferation and white matter maturation reduce MD (Table 2;
Alexander et al., 2012; Feldman et al., 2010).
Both FA and MD values are aﬀected by ﬁbre crossings and
orientation dispersion, ubiquitous brain features, which confound the
relation with other patho-physiological phenomena. This hampers the
neurobiological interpretation of signal abnormalities, as they can be
due to microsctructural changes or can be caused by neural circuitry
variations resulting in a modiﬁed distribution of the neurite orientation.
A robust biomarker for cortical and subcortical microstructure
needs to be unaﬀected by orientation dispersion and crossing ﬁbres
(Kaden et al., 2016a), which naturally diﬀer between subjects. How-
ever, both FA and MD values are aﬀected by these confounding factors,
hampering the neurobiological interpretation of signal abnormalities.
Another limitation of standard FA and MD maps is that they do not
account for the presence of diﬀerent tissue components, such as
neurons, microglia and extracellular space, across which diﬀusion
parameters diﬀer (Kaden et al., 2016a).
Recent improvements in data acquisition and modelling, such as
neurite orientation dispersion and density imaging (NODDI) (Zhang
et al., 2012) and multi-compartment microscopic diﬀusion (Kaden
et al., 2016a), enable the separation of eﬀects of ﬁbre crossings and
orientation dispersion within diﬀerent tissue compartments (Kaden
et al., 2016a, 2016b; Zhang et al., 2012), allowing more speciﬁc
estimation of diﬀusion parameters.
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The intra-cellular volume fraction of NODDI represents the space
within the membrane of neurites (Table 2). The signal relative to this
environment is further characterised by neurite orientation, a feature
distinguishing highly coherently oriented white matter structures,
white matter areas with bending and fanning axons, cortical and
subcortical grey matter structures composed by sprawling dendritic
processes in all directions (Zhang et al., 2012; Sotiropoulos et al.,
2012). The extra-cellular volume fraction represents the space around
neurites, where glial cells and cell bodies, in grey matter, are present
(Table 2; Zhang et al., 2012). In this space, the signal is characterised
with anisotropic Gaussian diﬀusion model, as the presence of neurites
hinders water molecules diﬀusion (Zhang et al., 2012). The CSF
compartment, referring to the space occupied by cerebrospinal ﬂuid,
allows to minimize the confounding eﬀect of CSF-contamination,
especially in the periventricular white matter regions (Zhang et al.,
2012).
The microscopic FA of the multi-compartment model provides
separate measures for the diﬀusion anisotropy of water molecules
inside and outside the neurites, as the two pools have diﬀerent
contribution to the diﬀusion signal (Table 2; Kaden et al., 2016a).
Unlike the standard FA metrics, this novel parameter is invariant to the
ﬁbres' orientation, which physiologically varies between subjects, thus
microscopic FA can improve the detection of microstructural abnorm-
alities. Microscopic FA has been recently proved to be a sensitive
biomarker for microstructural changes associated to TSC in an animal
model (Kaden et al., 2016a).
The majority of diﬀusion models commonly used to disentangle the
eﬀects of ﬁbre crossings and orientation dispersion, rely on strong
assumptions or constraints. When the tissue properties signiﬁcantly
diﬀer from those constraints, the model can lead to erroneous inter-
pretations, as might be the case in cortical grey matter (Lampinen et al.,
2017). Despite the criticisms raised regarding the model assumptions
(Lampinen et al., 2017), NODDI is frequently used to study the human
brain cortex (Colgan et al., 2016; Eaton-Rosen et al., 2015; Nazeri et al.,
2016). In the context of FCD characterisation, it may be necessary to
reﬁne diﬀusion models to encompass the range of brain tissue micro-
structure present in the cortex. However, it must be noted that there is a
limit to the model complexity that current diﬀusion data can support.
For clinical purposes a robust model, even if biophysically inaccurate
for grey matter, may yield consistent signal changes related to FCD
pathology which in turn could aid diagnostic speciﬁcity.
6.6.1. Conclusion on qMRI
qMRI parameters are more speciﬁc than standard MRI to biophysi-
cal tissue properties changes. However multiple microstructural proper-
ties can elicit changes in each parameter's values, limiting its speciﬁ-
city. The combination of multiple quantitative parameters oﬀers an
approach to investigate and disentangle the contribution of diﬀerent
tissue properties to the MRI signal, allowing a more detailed character-
isation of the whole brain using non-invasive techniques (“in vivo
histology”) (Dinse et al., 2015; Stüber et al., 2014). For this goal to be
realised, determining the multivariate relationship between tissue
properties and qMRI parameters is an essential step (Mohammadi
et al., 2015). FCD oﬀers a unique opportunity for validation by
performing these MRI measurements in the human brain with the
subsequent analysis of surgically resected tissue (Fig. 1).
7. Quantitative MRI in focal cortical dysplasia detection
In FCD, qMRI has been used in lesion detection as well as region of
interest (ROI) studies to histologically characterise and subtype lesions.
In terms of lesion detection, diﬀusion tensor imaging shows decreased
subcortical ﬁbre connectivity in and around the region aﬀected by FCD
(Lee et al., 2004) and reduced intra-cellular volume fraction (ICVF) in
the lesion area (Winston et al., 2014). These ﬁndings are in agreement
with altered diﬀusion measures performed on histology samples
(Vargova et al., 2011). FA and MD are altered in the subcortical white
matter subjacent to the FCD as well as beyond the MR-visible
abnormality (Widjaja et al., 2009). However, alterations in FA and
MD distant from the FCD have also been reported (Eriksson et al., 2001;
de la Roque et al., 2005) and thus the general consensus is these
features are not speciﬁc enough for lesion classiﬁcation. Furthermore,
changes in diﬀusion measures/markers have been discovered in other
malformations of cortical development as well as in epilepsy patients
with normal MRI (Eriksson et al., 2001; Rugg-Gunn et al., 2001).
However, future work will be required to evaluate whether more
speciﬁc diﬀusion measures such as ICVF provide a greater utility for
FCD lesion classiﬁcation.
ROI studies have estimated the correlation between histology
measures and MRI parameters (Reeves et al., 2015). MT, T1, T2 and
T2* values are correlated with myelin alteration in the lesion/perile-
sional areas. FCD type IIA shows decreased T2 and T2* values with
respect to the mean values for normal cortex (Reeves et al., 2015).
Overall however, the qMRI signature of FCD subtypes is not yet well
deﬁned, mainly due to the lack of quantitative histopathology informa-
tion as well as incomplete knowledge about the relationship between
genetics, histopathology and qMRI parameters (Mühlebner et al.,
2011). The existing literature presents data in small patient samples,
often limited to a speciﬁc diagnosis (i.e. speciﬁc subtypes), which
increases the chance of bias and hampers generalisation.
8. Combinations of qMRI and morphometry measures in FCD
Individual qMRI parameters are unlikely to distinguish subtypes or
even detect all FCD lesions, as they are characterised by subtle and
overlapping features. As brain structure may be profoundly or subtly
aﬀected by the interplay of genetic and histological factors, successful
approaches are likely to entail the design of integrated methods to
model morphology, intensity and quantitative signals in a multivariate
framework.
Hong and colleagues combined quantitative MRI, morphological
and functional MRI features in a multivariate analysis using machine
learning algorithms (Hong et al., 2015, 2017) to classify lesion subtypes
(Fig. 2). The study used a surface-based analysis framework to include
anatomical, diﬀusion, and resting-state functional MRI (rsfMRI) mea-
sures, beneﬁtting from their covariance for improved lesion proﬁling.
Morphology features included cortical thickness and sulcal depth.
Intensity features included normalized T1-weighted and FLAIR signal
intensity as well as tangential and perpendicular intensity gradients.
Diﬀusion measures included fractional anisotropy and mean diﬀusivity.
Resting state fMRI features included amplitude of low frequency
ﬂuctuations (ALFF) in the 0.01–0.08 Hz band, and regional homogene-
ity (ReHo), a measure of the similarity between one voxel's time series
and its neighbours. Anomalies in FCD Type IIB were distributed
throughout the cortex and in the subcortical white matter, whereas
those in Type IIA clustered at the cortico-subcortical interface (Hong
et al., 2015). A supervised classiﬁer was reported to predict the FCD
subtype with 91% accuracy, exemplifying the ability of combinations of
qMRI and computational anatomical metrics to accurately subtype FCD
lesions.
FCDs are often associated with diﬀuse changes (Hong et al., 2016)
in the cortex and also in the white matter. One crucial advantage of in
vivo qMRI and morphometry is that they can provide whole-brain
measures that can be used to identify lesional and extra-lesional
characteristics of FCD subtypes within cortex and white matter. One
challenge for future studies will be in distinguishing true malformations
of cortical development from other secondary changes such as gliosis,
and is likely to require the correlation of computational or qMRI
features with the underlying histology. This will be integral in
accurately delineating the margins of the lesion for pre-surgical
evaluation, intra-operative guidance and patient counselling.
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9. Conclusions and future directions
The radiological literature regarding FCD subtyping highlights the
fact that it is impossible to reliably subtype a lesion based on one MRI
feature. However, radiologists are often able to estimate the histo-
pathological subtype with greater than chance accuracy. This suggests
that the combination of multiple features may improve accuracy of in
vivo classiﬁcation. Technological advances have shown that it is
increasingly possible to map quantitative MRI parameters in clinically
feasible scan times. At the same time the correlation between qMRI
parameters and tissue microstructure is the subject of intensive
investigation. This combined with computational approaches that allow
for the comparison of a wide range of imaging features at a local and
global level bring the possibility of MRI tissue classiﬁcation closer to the
clinical domain.
FCD is a unique pathology that oﬀers a continuum of tissue
organization and distinct changes to neuronal and glial cell types, as
well as access to histological classiﬁcation close to the time point of
imaging. Moreover the highly complex structure of the brain is strongly
shaped by genetic inﬂuences, with several genetic variants underlying
diﬀerences in lesion subtypes at the individual level (Conti et al., 2015;
Jansen et al., 2015; Mirzaa et al., 2016; Sim et al., 2016). On the one
hand multivariate analysis of qMRI and computational anatomy seems
well placed to characterise FCD lesion type non-invasively while on the
other histopathological and genetic analyses of the surgical resections
oﬀer the opportunity to validate the sensitivity and speciﬁcity of qMRI
to tissue properties. The ﬁrst studies using multivariate analysis for
lesion subtyping are now being published. Future studies will need to
include multiple quantitative and morphological features in large
datasets representative of the entire ILAE classiﬁcation system. The
creation of open source databases of diﬀerent image modalities and
FCD subtypes would facilitate the ability to conduct large-scale studies,
create new MR features and test machine learning capabilities. This
may open an avenue for new MRI methods to be incorporated into
clinical decision making; allowing non-invasive characterisation of the
lesion and more individualized surgical planning.
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